230 related articles for article (PubMed ID: 2850626)
1. PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent.
Tamminga CA; Tanimoto K; Kuo S; Chase TN; Contreras PC; Rice KC; Jackson AE; O'Donohue TL
Synapse; 1987; 1(5):497-504. PubMed ID: 2850626
[TBL] [Abstract][Full Text] [Related]
2. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
[TBL] [Abstract][Full Text] [Related]
3. Effects of metaphit, a proposed phencyclidine receptor acylator, on catalepsy in pigeons.
Koek W; Head R; Holsztynska EJ; Woods JH; Domino EF; Jacobson AE; Rafferty MF; Rice KC; Lessor RA
J Pharmacol Exp Ther; 1985 Sep; 234(3):648-53. PubMed ID: 2993588
[TBL] [Abstract][Full Text] [Related]
4. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
Koek W; Woods JH; Jacobson AE; Rice KC; Lessor RA
J Pharmacol Exp Ther; 1986 May; 237(2):386-92. PubMed ID: 3009781
[TBL] [Abstract][Full Text] [Related]
5. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
[TBL] [Abstract][Full Text] [Related]
6. A specific acylating agent for the [3H]phencyclidine receptors in rat brain.
Rafferty MF; Mattson M; Jacobson AE; Rice KC
FEBS Lett; 1985 Feb; 181(2):318-22. PubMed ID: 2982662
[TBL] [Abstract][Full Text] [Related]
7. Metaphit, a proposed phencyclidine receptor acylator: disruption of mouse motor behavior and absence of PCP antagonist activity.
Domino EF; Gole D; Koek W
J Pharmacol Exp Ther; 1987 Oct; 243(1):95-100. PubMed ID: 2822909
[TBL] [Abstract][Full Text] [Related]
8. Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator.
Snell LD; Johnson KM; Yi SJ; Lessor RA; Rice KC; Jacobson AE
Life Sci; 1987 Dec; 41(24):2645-54. PubMed ID: 2826948
[TBL] [Abstract][Full Text] [Related]
9. Interactions of metaphit with phencyclidine and sigma agonist actions in rat cerebellum: determination of specificity and selectivity.
Wang Y; Kim MB; Palmer MR
J Pharmacol Exp Ther; 1987 Apr; 241(1):321-7. PubMed ID: 3033207
[TBL] [Abstract][Full Text] [Related]
10. Electrophilic affinity ligands for the phencyclidine (PCP) receptor.
Lessor RA; Mattson MV; Rice KC; Jacobson AE
NIDA Res Monogr; 1986; 67():138-44. PubMed ID: 3018571
[No Abstract] [Full Text] [Related]
11. Alterations in local cerebral glucose utilization induced by phencyclidine.
Weissman AD; Dam M; London ED
Brain Res; 1987 Dec; 435(1-2):29-40. PubMed ID: 3427457
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
Snell LD; Johnson KM
J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
[TBL] [Abstract][Full Text] [Related]
14. Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays.
Contreras PC; Quirion R; O'Donohue TL
NIDA Res Monogr; 1986; 64():80-93. PubMed ID: 3012347
[No Abstract] [Full Text] [Related]
15. Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands.
Sircar R; Samaan H; Nichtenhauser R; Snell LD; Johnson KM; Rivier J; Vale W; Zukin RS; Zukin SR
NIDA Res Monogr; 1986; 75():157-60. PubMed ID: 2828962
[TBL] [Abstract][Full Text] [Related]
16. Effects of metaphit on phencyclidine and serotonin2 receptors.
Nabeshima T; Tohyama K; Noda A; Maeda Y; Hiramatsu M; Harrer SM; Kameyama T; Furukawa H; Jacobson AE; Rice KC
Neurosci Lett; 1989 Jul; 102(2-3):303-8. PubMed ID: 2554211
[TBL] [Abstract][Full Text] [Related]
17. Metaphit, a proposed phencyclidine (PCP) antagonist, prevents PCP-induced locomotor behavior through mechanisms unrelated to specific blockade of PCP receptors.
French ED; Jacobson AE; Rice KC
Eur J Pharmacol; 1987 Aug; 140(3):267-74. PubMed ID: 2820762
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological interactions of isomers of cyclazocine with the phencyclidine antagonist metaphit in rat cerebellar Purkinje neurons.
Wang Y; Palmer MR; Freedman R; Rice KC; Lessor RA; Jacobson AE; Hoffer BJ
J Neurosci; 1986 Nov; 6(11):3189-96. PubMed ID: 3021925
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an endogenous peptide ligand and antagonist for PCP receptors.
Contreras PC; DiMaggio DA; O'Donohue TL
Prog Clin Biol Res; 1985; 192():495-8. PubMed ID: 3001770
[TBL] [Abstract][Full Text] [Related]
20. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.
Kurumaji A; McCulloch J
J Cereb Blood Flow Metab; 1989 Dec; 9(6):786-94. PubMed ID: 2684992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
